NO941820D0 - N-tritylasparaginsyrederivater for fremstilling av fosfonat-NMDA-antagonister - Google Patents
N-tritylasparaginsyrederivater for fremstilling av fosfonat-NMDA-antagonisterInfo
- Publication number
- NO941820D0 NO941820D0 NO941820A NO941820A NO941820D0 NO 941820 D0 NO941820 D0 NO 941820D0 NO 941820 A NO941820 A NO 941820A NO 941820 A NO941820 A NO 941820A NO 941820 D0 NO941820 D0 NO 941820D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- tritylaspartic
- acid derivatives
- nmda antagonists
- phosphonate
- Prior art date
Links
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- KGMHYPXNXMMYOA-FQEVSTJZSA-N (2s)-2-(tritylamino)butanedioic acid Chemical class C=1C=CC=CC=1C(C=1C=CC=CC=1)(N[C@@H](CC(=O)O)C(O)=O)C1=CC=CC=C1 KGMHYPXNXMMYOA-FQEVSTJZSA-N 0.000 title 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 title 1
- HYHXAZMLKDGXEI-JOCHJYFZSA-N dimethyl (2r)-2-(tritylamino)butanedioate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(N[C@H](CC(=O)OC)C(=O)OC)C1=CC=CC=C1 HYHXAZMLKDGXEI-JOCHJYFZSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79283491A | 1991-11-15 | 1991-11-15 | |
| PCT/US1992/008739 WO1993010075A1 (en) | 1991-11-15 | 1992-10-13 | N-trityl aspartic acid derivatives for preparing phosphonate nmda antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO941820D0 true NO941820D0 (no) | 1994-05-13 |
| NO941820L NO941820L (no) | 1994-05-13 |
| NO305314B1 NO305314B1 (no) | 1999-05-10 |
Family
ID=25158215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO941820A NO305314B1 (no) | 1991-11-15 | 1994-05-13 | N-tritylasparaginsyrederivater samt fremstilling av fosfonat-NMDA-antagonister |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0613459B1 (no) |
| JP (1) | JP3168563B2 (no) |
| KR (1) | KR100241480B1 (no) |
| AT (1) | ATE134989T1 (no) |
| AU (1) | AU667845B2 (no) |
| CA (1) | CA2121835A1 (no) |
| DE (1) | DE69208888T2 (no) |
| DK (1) | DK0613459T3 (no) |
| ES (1) | ES2087555T3 (no) |
| FI (1) | FI942248A0 (no) |
| GR (1) | GR3019587T3 (no) |
| HU (1) | HU214055B (no) |
| IL (1) | IL103710A (no) |
| MX (1) | MX9206448A (no) |
| NO (1) | NO305314B1 (no) |
| WO (1) | WO1993010075A1 (no) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2025326C (en) * | 1989-09-19 | 2001-04-24 | Jeffrey P. Whitten | Nmda antagonists |
-
1992
- 1992-10-13 ES ES92921774T patent/ES2087555T3/es not_active Expired - Lifetime
- 1992-10-13 DK DK92921774.3T patent/DK0613459T3/da active
- 1992-10-13 AT AT92921774T patent/ATE134989T1/de not_active IP Right Cessation
- 1992-10-13 JP JP50924593A patent/JP3168563B2/ja not_active Expired - Fee Related
- 1992-10-13 WO PCT/US1992/008739 patent/WO1993010075A1/en active IP Right Grant
- 1992-10-13 CA CA002121835A patent/CA2121835A1/en not_active Abandoned
- 1992-10-13 AU AU28642/92A patent/AU667845B2/en not_active Ceased
- 1992-10-13 EP EP92921774A patent/EP0613459B1/en not_active Expired - Lifetime
- 1992-10-13 HU HU9401469A patent/HU214055B/hu not_active IP Right Cessation
- 1992-10-13 DE DE69208888T patent/DE69208888T2/de not_active Expired - Fee Related
- 1992-10-13 KR KR1019940701634A patent/KR100241480B1/ko not_active IP Right Cessation
- 1992-11-10 MX MX9206448A patent/MX9206448A/es not_active IP Right Cessation
- 1992-11-11 IL IL103710A patent/IL103710A/en not_active IP Right Cessation
-
1994
- 1994-05-13 FI FI942248A patent/FI942248A0/fi unknown
- 1994-05-13 NO NO941820A patent/NO305314B1/no not_active IP Right Cessation
-
1996
- 1996-04-09 GR GR960400979T patent/GR3019587T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0613459A1 (en) | 1994-09-07 |
| HU214055B (en) | 1997-12-29 |
| IL103710A (en) | 1998-02-08 |
| DE69208888T2 (de) | 1996-08-01 |
| MX9206448A (es) | 1993-05-01 |
| ATE134989T1 (de) | 1996-03-15 |
| IL103710A0 (en) | 1993-04-04 |
| ES2087555T3 (es) | 1996-07-16 |
| HUT70551A (en) | 1995-10-30 |
| CA2121835A1 (en) | 1993-05-27 |
| DK0613459T3 (da) | 1996-04-01 |
| DE69208888D1 (de) | 1996-04-11 |
| NO941820L (no) | 1994-05-13 |
| FI942248A (fi) | 1994-05-13 |
| WO1993010075A1 (en) | 1993-05-27 |
| KR100241480B1 (ko) | 2000-03-02 |
| FI942248A0 (fi) | 1994-05-13 |
| GR3019587T3 (en) | 1996-07-31 |
| AU2864292A (en) | 1993-06-15 |
| HU9401469D0 (en) | 1994-08-29 |
| NO305314B1 (no) | 1999-05-10 |
| EP0613459B1 (en) | 1996-03-06 |
| JP3168563B2 (ja) | 2001-05-21 |
| JPH07501523A (ja) | 1995-02-16 |
| AU667845B2 (en) | 1996-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO905608L (no) | Fremgangsmaate for fremstilling av a-nor-steroid-3-karboksylsyrederivater. | |
| NO914092D0 (no) | Fremgangsmaate for fremstilling av mercaptoacetylamidderivater | |
| ES2078257T3 (es) | Antagonistas de aminoacidos excitantes. | |
| NO914429L (no) | Fremgangsmaate for fremstilling av piperidinylkamfersulfonyloxytocin-antagonister | |
| ES2088011T3 (es) | Antagonistas de aminoacidos excitadores. | |
| ATE79637T1 (de) | Substituierte alkylamide von teicoplaninverbindungen. | |
| GR920100570A (el) | Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους. | |
| ES2135722T3 (es) | 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina. | |
| DE69104220D1 (de) | Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten. | |
| DE69230224D1 (de) | Potenzierung von nmda-antagonisten | |
| NO891894L (no) | Fremgangsmaate for fremstilling av antikoagulerende peptidalkoholer. | |
| NO301716B1 (no) | Fremgangsmåte for fremstilling av kalsium-L-askorbat-2-fosfat | |
| NO941820D0 (no) | N-tritylasparaginsyrederivater for fremstilling av fosfonat-NMDA-antagonister | |
| GR1001566B (el) | Μέ?οδος παρασκευής νέων παραγώγων βενζοφουρανυλιμιδαζόλης. | |
| FI103202B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 4-sulfonamido-1,4-dihydrokinoliiinijohdannaisten valmistamiseksi | |
| MX9204659A (es) | Nuevas 3-(tetrazolil substituido)-oxo-4h-pirido-(1,2-a)-pirimidinas, sales de los mismos, las composiciones farmaceuticas que contienen a los mismos y procedimientos para prepararlas | |
| ITMI912138A0 (it) | Procedimento per la preparazione di fosfatidi | |
| SE9502369D0 (sv) | Process for the preparation of compositions for inhalation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN APRIL 2001 |